Stockreport

MBX Biosciences Announces Pricing of Initial Public Offering

MBX Biosciences, Inc.  (MBX) 
PDF CARMEL, Ind., Sept. 12, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the dis [Read more]